Literature DB >> 17594341

Amyotrophic lateral sclerosis and Alzheimer's disease--clinical and neuropathological considerations in two cases.

R Rusina1, K Sheardová, I Rektorová, P Ridzon, P Kulist'ák, R Matej.   

Abstract

Amyotrophic lateral sclerosis (ALS) may be accompanied by cognitive impairment; when present, it is mainly in the form of frontotemporal impairment. We report on two cases with clinically defined ALS that subsequently developed dementia. Neuropathological examination showed not only the typical neuropathological hallmarks characteristic of ALS but, surprisingly, also showed neurofibrillary tangles and neuritic plaques in sufficient numbers to fulfill the diagnostic criteria of definite Alzheimer's disease.

Entities:  

Mesh：

Year:  2007        PMID： 17594341     DOI： 10.1111/j.1468-1331.2007.01759.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN： 1351-5101            Impact factor:   6.089


  5 in total

1.  Two cases of dementias with motor neuron disease evaluated by Pittsburgh compound B-positron emission tomography.

Authors:  Yoshihiro Yamakawa; Hiroyuki Shimada; Suzuka Ataka; Akiko Tamura; Hideki Masaki; Hiroshi Naka; Tsuyoshi Tsutada; Aki Nakanishi; Susumu Shiomi; Yasuyoshi Watanabe; Takami Miki
Journal:  Neurol Sci       Date:  2011-02-05       Impact factor: 3.307

2.  Amnesia in frontotemporal dementia with amyotrophic lateral sclerosis, masquerading Alzheimer's disease.

Authors:  A Yamanami-Irioka; T Uchihara; T Endo; T Irioka; M Watanabe; M Kitagawa; H Mizusawa
Journal:  Case Rep Neurol       Date:  2011-10-21

3.  Immununochemical Markers of the Amyloid Cascade in the Hippocampus in Motor Neuron Diseases.

Authors:  Ulises Gómez-Pinedo; Rocio N Villar-Quiles; Lucia Galán; Jordi A Matías-Guiu; Maria S Benito-Martin; Antonio Guerrero-Sola; Teresa Moreno-Ramos; Jorge Matías-Guiu
Journal:  Front Neurol       Date:  2016-11-08       Impact factor: 4.003

4.  Candidate SNP Markers of Familial and Sporadic Alzheimer's Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters.

Authors:  Petr Ponomarenko; Irina Chadaeva; Dmitry A Rasskazov; Ekaterina Sharypova; Elena V Kashina; Irina Drachkova; Dmitry Zhechev; Mikhail P Ponomarenko; Ludmila K Savinkova; Nikolay Kolchanov
Journal:  Front Aging Neurosci       Date:  2017-07-20       Impact factor: 5.750

5.  Spectrum of cognitive impairment in Korean ALS patients without known genetic mutations.

Authors:  Seong-il Oh; Aram Park; Hee-Jin Kim; Ki-Wook Oh; Hojin Choi; Min-Jung Kwon; Chang-Seok Ki; Hee-Tae Kim; Seung Hyun Kim
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.